Tennessee HB 1737: Drugs, Prescription - As introduced, caps the total amount that a health insurance carrier can require a covered patient with diabetes to pay for a 30-day supply of insulin at no more than $35; caps the total price that a person who supplies prescription insulin drugs into or within this state for use by a patient with diabetes can charge for a 30-day supply of insulin at no more than $35. - Amends TCA Title 8; Title 53; Title 56, Chapter 7; Title 63 and Title 71, Chapter 5.

Status: P2C, ref. to Insurance Committee (as of 2024-01-11)

State: Tennessee · Session: 113 · Bill: HB 1737

Subjects: Drugs, Prescription

Sponsors: Jones

View Tennessee HB 1737 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.